The pharmaceutical sector has refused to play ball in negotiations with the minister, by ruling out reductions in a mid-term review of the existing 2012 agreement.
Varadkar is right to seek reductions from manufacturers, which are represented by the Irish Pharmaceutical Healthcare Association (IPHA).
Successive reports from the OECD show that Ireland spends considerably more per capita on medicines than the vast majority of the EU.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team